Israel Englander’s Praxis Precision Medicines PRAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$333K Sell
995
-2,836
-74% -$898K ﹤0.01% 5055
2026
Q1
$1.23M Buy
+3,831
New +$1.19M ﹤0.01% 4231
2025
Q2
Sell
-69,181
Closed -$2.62M 6233
2025
Q1
$2.62M Sell
69,181
-81,711
-54% -$5.1M ﹤0.01% 3516
2024
Q4
$11.6M Buy
150,892
+146,723
+3,519% +$10.6M 0.01% 2036
2024
Q3
$240K Sell
4,169
-86,740
-95% -$4.69M ﹤0.01% 5334
2024
Q2
$3.76M Sell
90,909
-86,043
-49% -$4.07M ﹤0.01% 2987
2024
Q1
$10.8M Buy
176,952
+154,606
+692% +$6.94M ﹤0.01% 2112
2023
Q4
$498K Buy
22,346
+10,179
+84% +$183K ﹤0.01% 4645
2023
Q3
$312K Sell
12,167
-71,017
-85% -$1.34M ﹤0.01% 4915
2023
Q2
$1.43M Buy
83,184
+71,462
+610% +$1.09M ﹤0.01% 3749
2023
Q1
$142K Buy
11,722
+584
+5% +$24.6K ﹤0.01% 5299
2022
Q4
$398K Sell
11,138
-54,325
-83% -$1.69M ﹤0.01% 4914
2022
Q3
$2.23M Buy
65,463
+46,990
+254% +$2.34M ﹤0.01% 3642
2022
Q2
$679K Buy
18,473
+13,282
+256% +$1.42M ﹤0.01% 4717
2022
Q1
$795K Buy
5,191
+2,909
+127% +$598K ﹤0.01% 4747
2021
Q4
$674K Sell
2,282
-5,183
-69% -$1.52M ﹤0.01% 4778
2021
Q3
$2.07M Buy
7,465
+3,377
+83% +$916K ﹤0.01% 3866
2021
Q2
$1.12M Buy
4,088
+2,375
+139% +$850K ﹤0.01% 4564
2021
Q1
$842K Buy
+1,713
New +$1.22M ﹤0.01% 4375

Other funds holding PRAX

Israel Englander's PRAX Position: Q2 2026 in Review

Israel Englander reduced its Praxis Precision Medicines (PRAX) stake by 74% in Q2 2026, selling an estimated $898K and leaving 995 shares worth $333K. The position accounts for ﹤0.01% of the portfolio, ranked #5055.

Israel Englander first reported a position in PRAX in Q1 2021 and has held it in 19 quarters since. The position peaked at $11.6M in Q4 2024. 307 funds tracked by Wall St. Rank hold PRAX as of Q2 2026.

  • Israel Englander held 995 shares of Praxis Precision Medicines worth $333K as of Q2 2026.
  • Israel Englander sold 2,836 Praxis Precision Medicines shares in Q2 2026, an estimated $898K.
  • Praxis Precision Medicines made up ﹤0.01% of Israel Englander's portfolio in Q2 2026, its #5055 holding.
  • Israel Englander first reported a position in Praxis Precision Medicines in Q1 2021 and has held it in 19 quarters since.
  • Israel Englander's Praxis Precision Medicines position peaked at $11.6M in Q4 2024.
  • 307 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.